Quest Diagnostics
DGX
#1053
Rank
$15.74 B
Marketcap
$141.48
Share price
1.57%
Change (1 day)
3.38%
Change (1 year)
Quest Diagnostics is an American clinical laboratory company offering access to diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders and employment and court ordered drug testing.

EPS for Quest Diagnostics (DGX)

EPS in 2022 (TTM): $8.06

According to Quest Diagnostics 's latest financial reports the company's current EPS (TTM) is $8.06. In 2021 the company made an earnings per share (EPS) of $15.87 an increase over its 2020 EPS that were of $10.60.

EPS history for Quest Diagnostics from 2012 to 2022

Annual EPS

Year EPS Change
2022 (TTM)$8.06-49.21%
2021$15.8749.72%
2020$10.6066.67%
2019$6.3618%
2018$5.39-4.26%
2017$5.6323.19%
2016$4.57-7.11%
2015$4.9228.46%
2014$3.83-31.61%
2013$5.6060.46%
2012$3.49

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$13.93 72.83%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.36-104.47%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.16-114.39%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.85-77.05%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
-$0.60-107.44%๐Ÿ‡บ๐Ÿ‡ธ USA